Supernus Pharmaceuticals Inc (SUPN) — Cash Flow-to-Debt Ratio
Supernus Pharmaceuticals Inc (SUPN) has a Cash Flow-to-Debt Ratio of 0.16x as of March 2026, meaning its operating cash flow of $66.52 Million could theoretically repay 0% of its total liabilities ($423.92 Million) in one year. See Supernus Pharmaceuticals Inc (SUPN) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Supernus Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Supernus Pharmaceuticals Inc across 18 annual periods. Also explore Supernus Pharmaceuticals Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Supernus Pharmaceuticals Inc (2008–2025)
Year-by-year debt coverage analysis for Supernus Pharmaceuticals Inc. For market capitalisation and broader financial context, see SUPN market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | $47.33 Million | $390.93 Million | ▼ -76.6% |
| 2024 | 0.52x | $171.95 Million | $332.34 Million | ▲ +65.9% |
| 2023 | 0.31x | $111.08 Million | $356.16 Million | ▲ +117.9% |
| 2022 | 0.14x | $116.83 Million | $816.30 Million | ▼ -1.7% |
| 2021 | 0.15x | $127.13 Million | $873.30 Million | ▼ -20.1% |
| 2020 | 0.18x | $138.40 Million | $759.24 Million | ▼ -28.1% |
| 2019 | 0.25x | $143.13 Million | $564.85 Million | ▲ +3.1% |
| 2018 | 0.25x | $128.99 Million | $524.79 Million | ▼ -66.3% |
| 2017 | 0.73x | $114.64 Million | $156.98 Million | ▲ +28.8% |
| 2016 | 0.57x | $66.81 Million | $117.81 Million | ▲ +23.3% |
| 2015 | 0.46x | $32.12 Million | $69.86 Million | ▲ +293.4% |
| 2014 | 0.12x | $7.73 Million | $66.15 Million | ▲ +115.6% |
| 2013 | -0.75x | $-57.95 Million | $77.53 Million | ▲ +42.3% |
| 2012 | -1.30x | $-47.20 Million | $36.42 Million | ▼ -58.6% |
| 2011 | -0.82x | $-36.19 Million | $44.29 Million | ▼ -129.3% |
| 2010 | -0.36x | $-32.54 Million | $91.33 Million | ▼ -1264.2% |
| 2009 | 0.03x | $2.63 Million | $86.06 Million | ▲ +108.7% |
| 2008 | -0.35x | $-29.65 Million | $83.88 Million | — |